Pfizer sees ‘opportunity’ to hike price for COVID-19 vaccine, CFO says

Pfizer is looking to turn its lucrative coronavirus vaccine into an even bigger cash cow. The drugmaker sees a “significant opportunity” to charge more for the groundbreaking shot once it gets to the other side of the COVID-19 pandemic, one top executive says. Pfizer set the current prices for the vaccine it developed with its...

Top News